Jessica Donington to Radiopharmaceuticals
This is a "connection" page, showing publications Jessica Donington has written about Radiopharmaceuticals.
Connection Strength
0.428
-
Invited commentary. Ann Thorac Surg. 2012 Feb; 93(2):403-4.
Score: 0.344
-
Metabolic tumor burden predicts for disease progression and death in lung cancer. Int J Radiat Oncol Biol Phys. 2007 Oct 01; 69(2):328-33.
Score: 0.064
-
Tumor volume as a potential imaging-based risk-stratification factor in trimodality therapy for locally advanced non-small cell lung cancer. J Thorac Oncol. 2011 May; 6(5):920-6.
Score: 0.020